Amphastar Pharmaceuticals reported a gross margin of 50.83% and a net margin of 16.50% for the quarter ended Jun 2026. These financial ratios cover 53 quarters of results from Jun 2013 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Jun2013 | Sep2013 | Dec2013 | Mar2014 | Jun2014 | Sep2014 | Dec2014 | Mar2015 | Jun2015 | Sep2015 | Dec2015 | Mar2016 | Jun2016 | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Gross Margin | 45.62% | 46.52% | 46.38% | 51.31% | 48.71% | 52.71% | 52.73% | 49.92% | 60.04% | 53.98% | 52.43% | 52.18% | 53.31% | 46.45% | 49.99% | 49.59% | 51.42% | 46.79% | 41.08% | 50.83% | |||||||||||||||||||||||||||||||||
| EBT Margin | 33.55% | 22.47% | 24.12% | 18.75% | 18.81% | 38.83% | 23.97% | 22.52% | 35.25% | 29.14% | 27.86% | 27.55% | 24.94% | 26.47% | 18.10% | 22.55% | 11.21% | 20.34% | 5.87% | 20.96% | |||||||||||||||||||||||||||||||||
| EBIT Margin | 22.08% | 20.06% | 17.96% | 20.10% | 19.34% | 28.02% | 23.88% | 25.32% | 40.25% | 30.31% | 27.94% | 30.27% | 29.83% | 24.20% | 21.87% | 24.19% | 13.20% | 19.45% | 7.96% | 21.60% | |||||||||||||||||||||||||||||||||
| EBITDA Margin | 22.08% | 20.06% | 17.96% | 20.10% | 19.34% | 28.02% | 23.88% | 25.32% | 40.25% | 30.31% | 27.94% | 30.27% | 29.83% | 24.20% | 21.87% | 24.19% | 13.20% | 19.45% | 7.96% | 21.60% | |||||||||||||||||||||||||||||||||
| Operating Margin | 22.08% | 20.06% | 17.96% | 20.10% | 19.34% | 28.02% | 23.88% | 25.32% | 40.25% | 30.31% | 27.94% | 30.27% | 29.83% | 24.20% | 21.87% | 24.19% | 13.20% | 19.45% | 7.96% | 21.60% | |||||||||||||||||||||||||||||||||
| Net Margin | 27.59% | 16.52% | 20.73% | 14.25% | 13.35% | 21.67% | 19.15% | 18.14% | 27.48% | 18.74% | 25.46% | 20.81% | 21.14% | 14.07% | 14.83% | 17.79% | 9.04% | 16.02% | 3.75% | 16.50% | |||||||||||||||||||||||||||||||||
| FCF Margin | -4.14% | 27.76% | 36.60% | -2.09% | 12.28% | 6.60% | 22.07% | 31.48% | 29.99% | 8.10% | 27.06% | 34.58% | 24.15% | 8.91% | 14.30% | 14.35% | 24.62% | 13.43% | 22.39% | 23.24% | |||||||||||||||||||||||||||||||||
| Efficiency | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Inventory AverageInventory Avg. | 99.09M | 96.52M | 93.98M | 96.94M | 100.99M | 103.42M | 103.62M | 104.13M | 107.30M | 107.91M | 110.66M | 118.95M | 126.36M | 142.03M | 169.61M | 188.60M | 188.83M | 181.41M | 173.54M | 175.05M | |||||||||||||||||||||||||||||||||
| Assets AverageAssets Avg. | 658.71M | 661.60M | 693.88M | 719.98M | 725.21M | 734.34M | 757.82M | 1,075.96M | 1,461.45M | 1,528.77M | 1,543.61M | 1,532.92M | 1,518.35M | 1,561.32M | 1,601.87M | 1,620.80M | 1,640.78M | 1,647.76M | 1,638.73M | 1,695.96M | |||||||||||||||||||||||||||||||||
| Invested CapitalInvested Cap. | 507.98M | 522.50M | 556.03M | 575.24M | 580.86M | 604.54M | 623.62M | 1,090.43M | 1,233.78M | 1,229.44M | 1,266.79M | 1,300.45M | 1,324.38M | 1,334.16M | 1,355.37M | 1,366.14M | 1,386.25M | 1,399.19M | 1,384.86M | 1,380.21M | |||||||||||||||||||||||||||||||||
| Asset Utilization RatioAsset Util. | 0.63 | 0.66 | 0.66 | 0.66 | 0.67 | 0.68 | 0.68 | 0.50 | 0.41 | 0.42 | 0.44 | 0.47 | 0.48 | 0.47 | 0.46 | 0.45 | 0.44 | 0.44 | 0.44 | 0.43 | |||||||||||||||||||||||||||||||||
| Leverage & Solvency | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | 47.00 | 144.36 | 60.88 | 62.53 | 41.04 | 71.65 | 84.00 | 10.24 | 5.30 | 5.71 | 5.58 | 6.41 | 8.52 | 7.03 | 5.93 | 6.72 | 4.03 | 5.37 | 2.08 | 5.97 | |||||||||||||||||||||||||||||||||
| Debt Ratio | 0.12 | 0.11 | 0.11 | 0.10 | 0.10 | 0.10 | 0.10 | 0.36 | 0.41 | 0.39 | 0.38 | 0.39 | 0.39 | 0.38 | 0.37 | 0.38 | 0.37 | 0.37 | 0.37 | 0.35 | |||||||||||||||||||||||||||||||||
| Times Interest Earned | 47.00 | 144.36 | 60.88 | 62.53 | 41.04 | 71.65 | 84.00 | 10.24 | 5.30 | 5.71 | 5.58 | 6.41 | 8.52 | 7.03 | 5.93 | 6.72 | 4.03 | 5.37 | 2.08 | 5.97 | |||||||||||||||||||||||||||||||||
| Valuation | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Price to EarningsP/E | 29.46 | 55.65 | 70.13 | 96.84 | 85.18 | 46.08 | 67.37 | 106.17 | 44.40 | 89.07 | 49.02 | 51.61 | 58.07 | 67.39 | 54.66 | 34.40 | 71.19 | 41.68 | 136.20 | 28.28 | |||||||||||||||||||||||||||||||||
| Price to SalesP/S | 8.13 | 9.19 | 14.54 | 13.80 | 11.37 | 9.98 | 12.90 | 19.25 | 12.20 | 16.69 | 12.48 | 10.74 | 12.28 | 9.48 | 8.10 | 6.12 | 6.44 | 6.68 | 5.11 | 4.67 | |||||||||||||||||||||||||||||||||
| Price to BookP/B | 2.12 | 2.49 | 3.65 | 3.41 | 2.70 | 2.55 | 3.29 | 4.76 | 3.70 | 4.65 | 3.19 | 2.75 | 3.23 | 2.41 | 1.84 | 1.41 | 1.59 | 1.55 | 1.13 | 1.12 | |||||||||||||||||||||||||||||||||
| Enterprise Value | 797.52M | 974.61M | 1,563.19M | 1,521.05M | 1,181.93M | 1,172.34M | 1,613.83M | 2,642.48M | 1,902.97M | 2,716.25M | 1,855.07M | 1,740.72M | 2,097.05M | 1,546.40M | 1,145.08M | 835.67M | 958.99M | 939.57M | 582.48M | 568.18M | |||||||||||||||||||||||||||||||||
| EV to EBIT | 32.20 | 40.19 | 72.32 | 61.28 | 50.88 | 30.99 | 48.27 | 71.62 | 26.18 | 50.32 | 38.64 | 31.53 | 36.76 | 34.25 | 30.70 | 19.81 | 37.87 | 26.39 | 42.74 | 14.30 | |||||||||||||||||||||||||||||||||
| EV to EBITDA | 32.20 | 40.19 | 72.32 | 61.28 | 50.88 | 30.99 | 48.27 | 71.62 | 26.18 | 50.32 | 38.64 | 31.53 | 36.76 | 34.25 | 30.70 | 19.81 | 37.87 | 26.39 | 42.74 | 14.30 | |||||||||||||||||||||||||||||||||
| Market Capitalization | 912.15M | 1,111.28M | 1,750.20M | 1,704.44M | 1,366.01M | 1,348.10M | 1,806.72M | 2,805.62M | 2,202.85M | 2,973.06M | 2,144.62M | 1,958.50M | 2,347.54M | 1,768.04M | 1,381.96M | 1,067.42M | 1,235.20M | 1,222.39M | 874.44M | 858.30M | |||||||||||||||||||||||||||||||||
| Price to FCFP/FCF | -196.16 | 33.11 | 39.73 | -661.41 | 92.60 | 151.20 | 58.46 | 61.17 | 40.69 | 206.15 | 46.12 | 31.06 | 50.85 | 106.43 | 56.68 | 42.65 | 26.15 | 49.71 | 22.81 | 20.09 | |||||||||||||||||||||||||||||||||
| EV to FCF | -171.51 | 29.04 | 35.48 | -590.24 | 80.12 | 131.49 | 52.22 | 57.61 | 35.15 | 188.34 | 39.90 | 27.60 | 45.42 | 93.08 | 46.97 | 33.39 | 20.30 | 38.21 | 15.20 | 13.30 | |||||||||||||||||||||||||||||||||
| EV to CFO | 310.44 | 24.10 | 30.79 | 540.34 | 58.01 | 77.00 | 39.96 | 48.11 | 29.58 | 113.82 | 33.55 | 25.19 | 34.97 | 53.28 | 32.64 | 23.48 | 18.24 | 28.59 | 12.18 | 11.07 | |||||||||||||||||||||||||||||||||
| Return Ratios | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | 22.08% | 20.06% | 17.96% | 20.10% | 19.34% | 28.02% | 23.88% | 25.32% | 40.25% | 30.31% | 27.94% | 30.27% | 29.83% | 24.20% | 21.87% | 24.19% | 13.20% | 19.45% | 7.96% | 21.60% | |||||||||||||||||||||||||||||||||
| Return on Capital Employed [ROCE]ROCE | 8.65% | 12.53% | 14.01% | 15.49% | 15.07% | 16.81% | 18.29% | 15.93% | 15.03% | 15.11% | 16.42% | 16.47% | 15.76% | 14.80% | 13.88% | 12.58% | 10.44% | 9.43% | 7.92% | 7.98% | |||||||||||||||||||||||||||||||||
| Return on Invested Capital [ROIC]ROIC | 7.19% | 10.24% | 11.77% | 13.49% | 12.52% | 12.53% | 13.23% | 10.68% | 11.27% | 11.98% | 13.23% | 13.80% | 12.84% | 11.75% | 10.56% | 9.82% | 7.71% | 8.05% | 6.52% | 6.43% | |||||||||||||||||||||||||||||||||
| Return on Assets [ROA]ROA | 5.73% | 9.60% | 12.18% | 12.98% | 10.83% | 11.96% | 11.84% | 9.16% | 9.04% | 8.91% | 9.92% | 10.74% | 10.24% | 9.50% | 8.11% | 7.59% | 6.09% | 6.25% | 5.13% | 4.92% |